Chemomab Therapeutics (CMMB) Tax Provisions (2017 - 2023)

Chemomab Therapeutics' (CMMB) quarterly Tax Provisions came in at -$55000.0 in Q3 2023, down 261.76% on a QoQ basis from $34000.0 in Q2 2023.

Chemomab Therapeutics (CMMB) Tax Provisions (2017 - 2023) Analysis & Trends

Chemomab Therapeutics (CMMB) has 5 years of Tax Provisions data on file, last reported at -$55000.0 in Q3 2023.

Quarterly Tax Provisions changed N/A year-over-year to -$55000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $10000.0 (up 101.84% YoY) and the FY2022 annual result came in at -$534000.0, changed N/A from the prior year.
Tax Provisions retreated to -$55000.0 in Q3 2023, from $34000.0 in the prior quarter.
In the past five years, Tax Provisions ranged from a high of $1.3 million in Q4 2019 to a low of -$544000.0 in Q2 2022.
A 3-year average of $73444.4 and a median of $21000.0 in 2023 frame the typical range for Tax Provisions.
The widest YoY moves for Tax Provisions: up 743.12% in 2019, down 736.76% in 2019.
Tracing CMMB's Tax Provisions over 3 years: stood at $1.3 million in 2019, then slumped by 99.26% to $10000.0 in 2022, then slumped by 650.0% to -$55000.0 in 2023.
The last three Tax Provisions figures came in at -$55000.0 (Q3 2023), $34000.0 (Q2 2023), and $21000.0 (Q1 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	59.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	15.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	75.45 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	13.31 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-90.33 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	1.90 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Chemomab Therapeutics	13.62 Mn	3.25 Mn	-	-

Download Data